
The emergence and transmission of carbapenem-resistant Klebsiella pneumoniae (CRKP) have been recognized as a major public health concern. Here, we investigated the molecular epidemiology and its correlation with the mechanisms of resistance in CRKP isolates by compiling studies on the molecular epidemiology of CRKP strains worldwide. CRKP is increasing worldwide, with poorly characterized epidemiology in many parts of the world. Biofilm formation, high efflux pump gene expression, elevated rates of resistance, and the presence of different virulence factors in various clones of K. pneumoniae strains are important health concerns in clinical settings. A wide range of techniques has been implemented to study the global epidemiology of CRKP, such as conjugation assays, 16S-23S rDNA, string tests, capsular genotyping, multilocus sequence typing, whole-genome sequencing-based surveys, sequence-based PCR, and pulsed-field gel electrophoresis. There is an urgent need to conduct global epidemiological studies on multidrug-resistant infections of K. pneumoniae across all healthcare institutions worldwide to develop infection prevention and control strategies. In this review, we discuss different typing methods and resistance mechanisms to explore the epidemiology of K. pneumoniae pertaining to human infections.
Citation: Sunil Kumar, Razique Anwer, Arezki Azzi. Molecular typing methods & resistance mechanisms of MDR Klebsiella pneumoniae[J]. AIMS Microbiology, 2023, 9(1): 112-130. doi: 10.3934/microbiol.2023008
[1] | Weerawat Sudsutad, Chatthai Thaiprayoon, Sotiris K. Ntouyas . Existence and stability results for ψ-Hilfer fractional integro-differential equation with mixed nonlocal boundary conditions. AIMS Mathematics, 2021, 6(4): 4119-4141. doi: 10.3934/math.2021244 |
[2] | Weerawat Sudsutad, Wicharn Lewkeeratiyutkul, Chatthai Thaiprayoon, Jutarat Kongson . Existence and stability results for impulsive (k,ψ)-Hilfer fractional double integro-differential equation with mixed nonlocal conditions. AIMS Mathematics, 2023, 8(9): 20437-20476. doi: 10.3934/math.20231042 |
[3] | Songkran Pleumpreedaporn, Chanidaporn Pleumpreedaporn, Weerawat Sudsutad, Jutarat Kongson, Chatthai Thaiprayoon, Jehad Alzabut . On a novel impulsive boundary value pantograph problem under Caputo proportional fractional derivative operator with respect to another function. AIMS Mathematics, 2022, 7(5): 7817-7846. doi: 10.3934/math.2022438 |
[4] | Naimi Abdellouahab, Keltum Bouhali, Loay Alkhalifa, Khaled Zennir . Existence and stability analysis of a problem of the Caputo fractional derivative with mixed conditions. AIMS Mathematics, 2025, 10(3): 6805-6826. doi: 10.3934/math.2025312 |
[5] | Tamer Nabil . Ulam stabilities of nonlinear coupled system of fractional differential equations including generalized Caputo fractional derivative. AIMS Mathematics, 2021, 6(5): 5088-5105. doi: 10.3934/math.2021301 |
[6] | Sunisa Theswan, Sotiris K. Ntouyas, Jessada Tariboon . Coupled systems of ψ-Hilfer generalized proportional fractional nonlocal mixed boundary value problems. AIMS Mathematics, 2023, 8(9): 22009-22036. doi: 10.3934/math.20231122 |
[7] | Choukri Derbazi, Hadda Hammouche . Caputo-Hadamard fractional differential equations with nonlocal fractional integro-differential boundary conditions via topological degree theory. AIMS Mathematics, 2020, 5(3): 2694-2709. doi: 10.3934/math.2020174 |
[8] | Muath Awadalla, Manigandan Murugesan, Manikandan Kannan, Jihan Alahmadi, Feryal AlAdsani . Utilizing Schaefer's fixed point theorem in nonlinear Caputo sequential fractional differential equation systems. AIMS Mathematics, 2024, 9(6): 14130-14157. doi: 10.3934/math.2024687 |
[9] | Naveed Iqbal, Azmat Ullah Khan Niazi, Ikram Ullah Khan, Rasool Shah, Thongchai Botmart . Cauchy problem for non-autonomous fractional evolution equations with nonlocal conditions of order (1,2). AIMS Mathematics, 2022, 7(5): 8891-8913. doi: 10.3934/math.2022496 |
[10] | Zaid Laadjal, Fahd Jarad . Existence, uniqueness and stability of solutions for generalized proportional fractional hybrid integro-differential equations with Dirichlet boundary conditions. AIMS Mathematics, 2023, 8(1): 1172-1194. doi: 10.3934/math.2023059 |
The emergence and transmission of carbapenem-resistant Klebsiella pneumoniae (CRKP) have been recognized as a major public health concern. Here, we investigated the molecular epidemiology and its correlation with the mechanisms of resistance in CRKP isolates by compiling studies on the molecular epidemiology of CRKP strains worldwide. CRKP is increasing worldwide, with poorly characterized epidemiology in many parts of the world. Biofilm formation, high efflux pump gene expression, elevated rates of resistance, and the presence of different virulence factors in various clones of K. pneumoniae strains are important health concerns in clinical settings. A wide range of techniques has been implemented to study the global epidemiology of CRKP, such as conjugation assays, 16S-23S rDNA, string tests, capsular genotyping, multilocus sequence typing, whole-genome sequencing-based surveys, sequence-based PCR, and pulsed-field gel electrophoresis. There is an urgent need to conduct global epidemiological studies on multidrug-resistant infections of K. pneumoniae across all healthcare institutions worldwide to develop infection prevention and control strategies. In this review, we discuss different typing methods and resistance mechanisms to explore the epidemiology of K. pneumoniae pertaining to human infections.
Fractional calculus (FC), also known as non-integer calculus, has been widely studied in recent over the past decades (beginning 1695) in fields of applied sciences and engineering. FC deals with fractional-order integral and differential operators, which establishes phenomenon model as an increasingly realistic tool for real-world problems. In addition, it has been properly specified the term "memory" particularly in mathematics, physics, chemistry, biology, mechanics, electricity, finance, economics and control theory, we recommend these books to readers who require to learn more about the core ideas of fractional operators [1,2,3,4,5,6]. However, recently, several types of fractional operators have been employed in research education that mostly focus on the Riemann-Liouville (RL) [3], Caputo [3], Hadamard [3], Katugampola [7], conformable [8] and generalized conformable [9]. In 2017, Jarad et al. [10] introduced generalized RL and Caputo proportional fractional derivatives including exponential functions in their kernels. After that, in 2021, new fractional operators combining proportional and classical differintegrals have been introduced in [11]. Moreover, Akgül and Baleanu [12] studied the stability analysis and experiments of the proportional Caputo derivative.
Recently, one type of fractional operator that is popular with researchers now is proportional fractional derivative and integral operators (PFDOs/PFIOs) with respect to another function; for more details see [13,14]. For α>0, ρ∈(0,1], ψ∈C1([a,b]), ψ′>0, the PFIO of order α of h∈L1([a,b]) with respect to ψ is given as:
ρIα,ψa[h(t)]=1ραΓ(α)∫taρHα−1ψ(t,s)[h(s)]ψ′(s)ds, | (1.1) |
where Γ(α)=∫∞0sα−1e−sds, s>0, and
ρHα−1ψ(t,s)=eρ−1ρ(ψ(t)−ψ(s))(ψ(t)−ψ(s))α−1. | (1.2) |
The Riemann-Liouville proportional fractional derivative (RL-PFD) of order α of h∈Cn([a,b]) with respect to ψ is given by
ρDα,ψa[h(t)]=ρDn,ψρaIn−α,ψ[h(t)]=ρDn,ψtρn−αΓ(n−α)∫taρHn−α−1ψ(t,s)[h(s)]ψ′(s)ds, | (1.3) |
with n=[α]+1, where [α] denotes the integer part of order α, ρDn,ψ=ρDψ⋅ρDψ⋯ρDψ⏟ntimes, and ρDψ[h(t)]=(1−ρ)h(t)+ρh′(t))/ψ′(t). The PFD in Caputo type is given as in
CρDα,ψa[h(t)]=ρIn−α,ψa[ρDn,ψ[h(t)]]=ρα−nΓ(n−α)∫taρHn−α−1ψ(t,s)ρDn,ψ[h(s)]ψ′(s)ds. | (1.4) |
The relation of PFI and Caputo-PFD which will be used in this manuscript as
ρIα,ψa[CρDα,ψa[h(t)]]=h(t)−n−1∑k=0ρDk,ψ[h(a)]ρkk!ρHk+1ψ(t,a). | (1.5) |
Moreover, for α, β>0 and ρ∈(0,1], we have the following properties
ρIα,ψa[ρHβ−1ψ(t,a)]=Γ(β)ραΓ(β+α)ρHβ+α−1ψ(t,a), | (1.6) |
CρDα,ψa+[ρHβ−1ψ(t,a)]=ραΓ(β)Γ(β−α)ρHβ−α−1ψ(t,a). | (1.7) |
Notice that if we set ρ=1 in (1.1), (1.3) and (1.4), then we have the RL-fractional operators [3] with ψ(t)=t, the Hadamard fractional operators [3] with ψ(t)=logt, the Katugampola fractional operators [7] with ψ(t)=tμ/μ, μ>0, the conformable fractional operators [8] with ψ(t)=(t−a)μ/μ, μ>0 and the generalized conformable fractional operators [9] with ψ(t)=tμ+ϕ/(μ+ϕ), respectively. Recent interesting results on PFOs with respect to another function could be mention in [15,16,17,18,19,20,21,22,23,24,25].
Exclusive investigations in concepts of qualitative property in fractional-order differential equations (FDEs) have recently gotten a lot of interest from researchers as existence property (EP) and Ulam's stability (US). The EP of solutions for FDEs with initial or boundary value conditions has been investigated applying classical/modern fixed point theorems (FPTs). As we know, US is four types like Hyers-Ulam stability (HU), generalized Hyers-Ulam stability (GHU), Hyers-Ulam-Rassias stability (HUR) and generalized Hyers-Ulam-Rassias stability (GHUR). Because obtaining accurate solutions to fractional differential equations problems is extremely challenging, it is beneficial in various of optimization applications and numerical analysis. As a result, it is requisite to develop concepts of US for these issues, since studying the properties of US does not need us to have accurate solutions to the proposed problems. This qualitative theory encourages us to obtain an efficient and reliable technique for solving fractional differential equations because there exists a close exact solution when the purpose problem is Ulam stable. We suggest some interesting papers about qualitative results of fractional initial/boundary value problems (IVPs/BVPs) involving many types of non-integer order, see [26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43] and references therein.
We are going to present some of the researches that inspired this manuscript. In recent years, pantograph equation (PE) is a type of proportional delay differential equation emerging in deterministic situations which first studied by Ockendon and Taylor [44]:
{u′(t)=μu(t)+κu(λt),a<t<T,u(0)=u0=A,0<λ<1,μ,κ∈R. | (1.8) |
The problem (1.8) has been a broad area of applications in applied branchs such as science, medicine, engineering and economics that use the sake of PEs to model some phenomena of the problem at present which depend on the previous states. For more evidences of PEs, see [45,46,47,48,49,50,51]. There are many researches of literature on nonlinear fractional differential equations involving a specific function with initial, boundary, or nonlocal conditions, for examples in 2013, Balachandran et al. [52] discussed the initial nonlinear PEs as follows:
{CDα[u(t)]=h(t,u(t),u(σt)),α∈(0,1],0<t<1,u(0)=u0,0<σ<1, | (1.9) |
where u0∈R, CDα denotes the Caputo fractional derivative of order α and h∈C([0,1]×R2,R). FC and FPTs were applied to discuss the existence properties of the solutions in their work. In 2018, Harikrishman and co-workers [53] examined the existence properties of ψ-Hilfer fractional derivative for nonlocal problem for PEs:
{HDα,β;ψa+[u(t)]=h(t,u(t),u(σt)),t∈(a,b),σ∈(0,1),α∈(0,1)I1−γ;ψa+[u(a)]=k∑i=1ciu(τi),τi∈(a,b],α≤γ=α+β−αβ, | (1.10) |
where HDα,β;ψa+ represents the ψ-Hilfer fractional derivative of order α and type β∈[0,1], I1−γ;ψa+ is RL-fractional integral of order 1−γ with respect to ψ so that ψ′>0 and h∈C([a,b]×R2,R). Asawasamrit and co-workers [54] used Schaefer's and Banach's FPTs to establish the existence properties of FDEs with mixed nonlocal conditions (MNCs) in 2019. In 2021, Boucenna et al. [55] investigated the existence and uniqueness theorem of solutions for a generalized proportional Caputo fractional Cauchy problem. They solved the proposed problem based on the decomposition formula. Amongst important fractional equations, one of the most interesting equations is the fractional integro-differential equations, which provide massive freedom to explain processes involving memory and hereditary properties, see [56,57].
Recognizing the importance of all parts that we mentioned above, motivated us to generate this paper which deals with the qualitative results to the Caputo proportional fractional integro-differential equation (PFIDE) with MNCs:
{CρDα,ψa+[u(t)]=f(t,u(t),u(λt),ρIω,ψa+[u(λt)],CρDα,ψa+[u(λt)]),t∈(a,T),m∑i=1γiu(ηi)+n∑j=1κjCρDβj,ψa+[u(ξj)]+k∑r=1σrρIδr,ψa+[u(θr)]=A, | (1.11) |
where CρDq,ψa+ is the Caputo-PFDO with respect to another increasing differentiable function ψ of order q={α,βj} via 0<βj<α≤1, j=1,2,…,n, 0<ρ≤1, 0<λ<1, ρIp,ψa+ is the PFIO with respect to another increasing differentiable function ψ of order p={ω,δr}>0 for r=1,2,…,k, 0<ρ≤1, γi,κj,σr,A∈R, 0≤a≤ηi,ξj,θr≤T, i=1,2,…,m, f∈C(J×R4,R), J=[a,T]. We use the help of the famous FPTs like Banach's, Leray-Schauder's nonlinear alternative and Krasnoselskii's to discuss the existence properties of the solutions for (1.11). Moreover, we employ the context of different kinds of US to discuss the stability analysis. The results are well demonstrated by numerical examples at last section.
The advantage of defining MNCs of the problem (1.11) is it covers many cases as follows:
● If we set κj=σr=0, then (1.11) is deducted to the proportional multi-point problem.
● If we set γi=σr=0, then (1.11) is deducted to the PFD multi-point problem.
● If we set γi=κj=0, then (1.11) is deducted to the PFI multi-point problem.
● If we set α=ρ=1, (1.11) emerges in nonlocal problems [58].
This work is collected as follows. Section 2 provides preliminary definitions. The existence results of solutions for (1.11) is studied in Section 3. In Section 4, stability analysis of solution for (1.11) in frame of HU, GHU, HUR and GHUR are given is established. Section 5 contains the example to illustrate the theoretical results. In addition, the summarize is provided in the last part.
Before proving, assume that E=C(J,R) is the Banach space of all continuous functions from J into R provided with ‖u‖=supt∈J{|u(t)|}. The symbol ρIq,ψa+[Fu(s)(c)] means that
ρIq,ρ,ψa+[Fu(c)]=1ρqΓ(q)∫caρHq−1ψ(c,s)[Fu(s)]ψ′(s)ds, |
where q={α,α−βj,α+δr}, c={t,ηi,ξj,θr}, and
Fu(t):=f(t,u(t),u(λt),ρIω,ψa+[u(λt)],Fu(λt)). | (2.1) |
In order to convert the considered problem into a fixed point problem, (1.11) must be transformed to corresponding an integral equation. We discuss the following key lemma.
Lemma 2.1. Let 0<βj<α≤1, j=1,2,…,n, ρ>0, δr, >0, r=1,2,…,k and Ω≠0. Then, the Caputo-PFIDE with MNCs:
{CρDα,ψa+[u(t)]=Fu(t),t∈(a,T),m∑i=1γiu(ηi)+n∑j=1κjCρDβj,ψa+[u(ξj)]+k∑r=1σrρIδr,ψa+[u(θr)]=A, | (2.2) |
is equivalent to the integral equation
u(t)=ρIα,ψa+[Fu(t)]+eρ−1ρ(ψ(t)−ψ(a))Ω(A−m∑i=1γiρIα,ψa+[Fu(ηi)]−n∑j=1κjρIα−βj,ψa+[Fu(ξj)]−k∑r=1σrρIα+δr,ψa+[Fu(θr)]), | (2.3) |
where
Ω=m∑i=1γieρ−1ρ(ψ(ηi)−ψ(a))+k∑r=1σrρHδr+1ψ(θr,a)ρδrΓ(1+δr). | (2.4) |
Proof. Suppose u is the solution of (2.2). By using (1.5), the integral equation can be rewritten as
u(t)=ρIα,ψa+[Fu(t)]+c1eρ−1ρ(ψ(t)−ψ(a)), | (2.5) |
where c1∈R. Taking CρDβj,ψa+ and ρIδr,ψa+ into (2.5) with (1.6) and (1.7), we obtain
CρDβj,ψa+[u(t)]=ρIα−βj,ψa+[Fu(t)],ρIδr,ψa+[u(t)]=ρIα+δr,ψa+[Fu(t)]+c1ρHδr+1ψ(t,a)ρδrΓ(1+δr). |
Applying the nonlocal conditions in (2.2), we have
A=m∑i=1γiρIα,ψa+[Fu(ηi)]+n∑j=1κjρIα−βj,ψa+[Fu(ξj)]+k∑r=1σrρIα+δr,ψa+[Fu(θr)]+c1(m∑i=1γieρ−1ρ(ψ(ηi)−ψ(a))+k∑r=1σrρHδr+1ψ(θr,a)ρδrΓ(1+δr)). |
Solving the above equation, we get the value
c1=1Ω(A−m∑i=1γiρIα,ψa+[Fu(ηi)]−n∑j=1κjρIα−βj,ψa+[Fu(ξj)]−k∑r=1σrρIα+δr,ψa+[Fu(θr)]), |
where Ω is given as in (2.4). Taking c1 in (2.5), we obtain (2.3).
On the other hand, it is easy to show by direct computing that u(t) is provided as in (2.3) verifies (2.2) via the given MNCs. The proof is done.
By using Lemma 2.1, we will set the operator K:E→E
(Ku)(t)=ρIα,ψa+[Fu(t)]+eρ−1ρ(ψ(t)−ψ(a))Ω(A−m∑i=1γiρIα,ψa+[Fu(ηi)]−n∑j=1κjρIα−βj,ψa+[Fu(ξj)]−k∑r=1σrρIα+δr,ψa+[Fu(θr)]), | (3.1) |
where K1, K2:E→E defined by
(K1u)(t)=ρIα,ψa+Fu(t), | (3.2) |
(K2u)(t)=eρ−1ρ(ψ(t)−ψ(a))Ω(A−m∑i=1γiρIα,ψa+[Fu(ηi)]−n∑j=1κjρIα−βj,ψa+[Fu(ξj)]−k∑r=1σrρIα+δr,ψa+[Fu(θr)]). | (3.3) |
Notice that Ku=K1u+K2u. It should be noted that (1.11) has solutions if and only if K has fixed points. Next, we are going to examine the existence properties of solutions for (1.11), which is discussed by employing Banach's FPT, Leray-Schauder's nonlinear alternative and Krasnoselskii's FPT. For the benefit of calculation in this work, we will provide the constants:
Θ(χ,σ)=(ψ(χ)−ψ(a))σρσΓ(σ+1), | (3.4) |
Λ=Θ(T,α)+1|Ω|(m∑i=1|γi|Θ(ηi,α)+n∑j=1|κj|Θ(ξj,α−βj)+k∑r=1|σr|Θ(θr,α+δr)). | (3.5) |
Firstly, the uniqueness result for (1.11) will be stidied by applying Banach's FPT.
Lemma 3.1. (Banach contraction principle [59]) Assume that B is a non-empty closed subset of a Banach space E. Then any contraction mapping K from B into itself has a unique fixed point.
Theorem 3.2. Let f∈C(J×R4,R)so that:
(H1) there exist constants L1>0, L2>0, 0<L3<1 so that
|f(t,u1,v1,w1,z1)−f(t,u2,v2,w2,z2)|≤L1(|u1−u2|+|v1−v2|)+L2|w1−w2|+L3|z1−z2|, |
∀ui, vi, wi, zi∈R, i=1,2, t∈J.
If
(2L1+L2Θ(T,ω)1−L3)Λ<1, | (3.6) |
then the Caputo-PFIDE with MNCs (1.11) has a unique solution on J, where (3.4) and (3.5) refers to Θ(T,ω) and Λ.
Proof. First, we will convert (1.11) into u=Ku, where K is given as in (3.1). Clearly, the fixed points of K are solutions to (1.11). By using the Banach's FPT, we are going to prove that K has a FP which is a unique solution of (1.11).
Define supt∈J|f(t,0,0,0,0)|:=M1<∞ and setting Br1:={u∈E:‖u‖≤r1} with
r1≥M1Λ1−L3+|A||Ω|1−(2L1+L2Θ(T,ω)1−L3)Λ, | (3.7) |
where Ω, Θ(T,ω) and Λ are given as in (2.4), (3.4) and (3.5). Clearly, Br1 is a bounded, closed and convex subset of E. We have divided the method of the proof into two steps:
Step I. We prove that KBr1⊂Br1.
For each u∈Br1, we obtain
|(Ku)(t)|≤ρIα,ψa+|Fu(t)|+eρ−1ρ(ψ(t)−ψ(a))|Ω|(|A|+m∑i=1|γi|ρIα,ψa+|Fu(ηi)|+n∑j=1|κj|ρIα−βj,ψa+|Fu(ξj)|+k∑r=1|σr|ρIα+δr,ψa+|Fu(θr)|). |
From the assumption (H1), it follows that
|Fu(t)|≤|f(t,u(t),u(λt),ρIω,ψa+[u(λt)],Fu(λt))−f(t,0,0,0,0)|+|f(t,0,0,0,0)|≤L1(|u(t)|+|u(λt)|)+L2|ρIω,ψa+[u(λt)]|+L3|Fu(λt)|+M1≤2L1‖u‖+L2‖u‖ρIω,ψa+[1](t)+L3‖Fu(⋅)‖+M1=(2L1+L2(ψ(T)−ψ(a))ωρωΓ(ω+1))‖u‖+L3‖Fu(⋅)‖+M1. |
Then
‖Fu(⋅)‖≤(2L1+L2Θ(T,ω))‖u‖+M11−L3. |
This implies that
|(Ku)(t)|≤ρIα,ψa+((2L1+L2Θ(T,ω))‖u‖+M11−L3)(t)+eρ−1ρ(ψ(t)−ψ(a))|Ω|[|A|+m∑i=1|γi|ρIα,ψa+((2L1+L2Θ(T,ω))‖u‖+M11−L3)(ηi)+n∑j=1|κj|ρIα−βj,ψa+((2L1+L2Θ(T,ω))‖u‖+M11−L3)(ξj)+k∑r=1|σr|ρIα+δr,ψa+((2L1+L2Θ(T,ω))‖u‖+M11−L3)(θr)]. |
By using the fact of 0<eρ−1ρ(ψ(t)−ψ(s))≤1, a≤s<t≤T, it follows that
|(Ku)(t)|≤((2L1+L2Θ(T,ω))‖u‖+M11−L3)((ψ(T)−ψ(a))αραΓ(α+1)+1|Ω|[m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a))α+δrρα+δrΓ(α+δr+1)])+|A||Ω|=((2L1+L2Θ(T,ω))‖u‖+M11−L3)(Θ(T,α)+1|Ω|[m∑i=1|γi|Θ(ηi,α)+n∑j=1|κj|Θ(ξj,α−βj)+k∑r=1|σr|Θ(θr,α+δr)])+|A||Ω|=(2L1+L2Θ(T,ω)1−L3)Λr1+M1Λ1−L3+|A||Ω|≤r1, |
which implies that ‖Ku‖≤r1. Thus, KBr1⊂Br1.
Step II. We prove that K:E→E is contraction.
For each u, v∈E, t∈J, we obtain
|(Ku)(t)−(Kv)(t)|≤ρIα,ψa+|Fu−Fv|(T)+eρ−1ρ(ψ(T)−ψ(a))|Ω|(m∑i=1|γi|ρIα,ψa+|Fu−Fv|(ηi)+n∑j=1|κj|ρIα−βj,ψa+|Fu−Fv|(ξj)+k∑r=1|σr|ρIα+δr,ψa+|Fu−Fv|(θr)). | (3.8) |
From (H1) again, we can compute that
|Fu(t)−Fv(t)|≤|f(t,u(t),u(λt),ρIω,ψa+[u(λt)],Fu(λt))−f(t,v(t),v(λt),ρIω,ψa+[v(λt)],Fv(λt))|≤L1(|u(t)−v(t)|+|u(λt)−v(λt)|)+L2ρIω,ψa+|u(λt)−v(λt)|+L3|Fu(λt)−Fv(λt)|≤2L1‖u−v‖+L2(ψ(T)−ψ(a))ωρωΓ(ω+1)‖u−v‖+L3‖Fu(⋅)−Fv(⋅)‖. |
Then
‖Fu(⋅)−Fv(⋅)‖≤(2L1+L2Θ(T,ω)1−L3)‖u−v‖. | (3.9) |
By inserting (3.9) into (3.8), one has
|(Ku)(t)−(Kv)(t)|≤ρIα,ψa+((2L1+L2Θ(T,ω)1−L3)‖u−v‖)(T)+eρ−1ρ(ψ(T)−ψ(a))|Ω|[m∑i=1|γi|ρIα,ψa+((2L1+L2Θ(T,ω)1−L3)‖u−v‖)(ηi)+n∑j=1|κj|ρIα−βj,ψa+((2L1+L2Θ(T,ω)1−L3)‖u−v‖)(ξj)+k∑r=1|σr|ρIα+δr,ψa+((2L1+L2Θ(T,ω)1−L3)‖u−v‖)(θr)]≤(2L1+L2Θ(T,ω)1−L3)[(ψ(T)−ψ(a))αραΓ(α+1)+1|Ω|(m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a))α+δrρα+δrΓ(α+δr+1))]‖u−v‖=(2L1+L2Θ(T,ω)1−L3)Λ‖u−v‖, |
also, ‖Ku−Kv‖≤(2L1+L2Θ(T,ω))/(1−L3)Λ‖u−v‖. It follows from [(2L1+L2Θ(T,ω))/(1−L3)]Λ<1, that K is contraction. Then, (from Lemma 3.1), we conclude that K has the unique fixed point, that is the unique solution to (1.11) in E.
Next, Leray-Schauder's nonlinear alternative is employed to analyze in the second property.
Lemma 3.3. (Leray-Schauder's nonlinear alternative [59]) Assume that E is a Banach space, C is a closed and convex subset of M, X is an open subset of C and 0∈X. Assume that F:¯X→C is continuous, compact (that is, F(¯X) is a relatively compact subset of C) map. Then either (i) F has a fixed point in ¯X, or (ii) there is x∈∂X (the boundary of X in C) and ϱ∈(0,1) with z=ϱF(z).
Theorem 3.4. Assume that f∈C(J×R4,R) so that:
(H2) there exists ΨC(R+,R+) and Ψ is non-decreasing, p, f∈C(J,R+), q∈C(J,R+∪{0}) so that
|f(t,u,v,w,z)|≤p(t)Ψ(|u|+|v|)+f(t)|w|+q(t)|z|,∀t∈J,∀u,v,w,z∈R, |
where p0=supt∈J{p(t)}, f0=supt∈J{f(t)}, q0=supt∈J{q(t)}<1.
(H3) there exists a constant N>0 so that
N|A||Ω|+(f0Θ(T,ω)N+2p0Ψ(N)1−q0)Λ>1, |
where Θ(T,ω) and Λ are given as in (3.4) and (3.5).
Then the Caputo-PFIDE with MNCs (1.11) has at least one solution.
Proof. Assume that K is given as in (3.1). Next, we are going to prove that K maps bounded sets (balls) into bounded sets in E. For any r2>0, assume that Br2:={u∈E:‖u‖≤r2}∈E, we have, for each t∈J,
|(Ku)(t)|≤ρIα,ψa+|Fu(T)|+eρ−1ρ(ψ(T)−ψ(a))|Ω|(|A|+m∑i=1|γi|ρIα,ψa+|Fu(ηi)|+n∑j=1|κj|ρIα−βj,ψa+|Fu(ξj)|+k∑r=1|σr|ρIα+δr,ψa+|Fu(θr)|). |
It follows from (H2) that
|CρDα,ψa+[u(t)]|≤p(t)Ψ(|u(t)|+|u(λt)|)+f(t)|ρIω,ψa+[u(λt)]|+q(t)|CρDα,ψa+[u(λt)]|≤p(t)Ψ(2‖u‖)+f(t)(ψ(T)−ψ(a))ωρωΓ(ω+1)‖u‖+q(t)|CρDα,ψa+[u(t)]|. |
Then, we have
|CρDα,ψa+u(t)|≤p(t)Ψ(2‖u‖)+f(t)Θ(T,ω)‖u‖1−q(t). |
For any a≤s<t≤T, we have 0<eρ−1ρ(ψ(t)−ψ(s))≤1, then
|(Ku)(t)|≤[(ψ(T)−ψ(a))αραΓ(α+1)+1|Ω|(m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a))α+δrρα+δrΓ(α+δr+1))](p0Ψ(2‖u‖)+f0Θ(T,ω)‖u‖1−q0)+|A||Ω|=(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)Λ+|A||Ω|, |
which leads to
‖Ku‖≤(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)Λ+|A||Ω|:=N. |
Now, we will prove that K maps bounded sets into equicontinuous sets of E.
Given τ1<τ2 where τ1, τ2∈J, and for each u∈Br2. Then, we obtain
|(Ku)(τ2)−(Ku)(τ1)|≤|ρIα,ψa+[Fu(τ2)]−ρIα,ψa+[Fu(τ1)]|+|eρ−1ρ(ψ(τ2)−ψ(a))−eρ−1ρ(ψ(τ1)−ψ(a))||Ω|(|A|+m∑i=1|γi|ρIα,ψa+|Fu(ηi)|+n∑j=1|κj|ρIα−βj,ψa+|Fu(ξj)|+k∑r=1|σr|ρIα+δr,ψa+|Fu(θr)|)≤(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)(1ραΓ(α)∫τ2τ1ρHα−1ψ(τ2,s)ψ′(s)ds+1ραΓ(α)∫τ1a|ρHα−1ψ(τ2,s)−ρHα−1ψ(τ1,s)|ψ′(s)ds)+|eρ−1ρ(ψ(τ2)−ψ(a))−eρ−1ρ(ψ(τ1)−ψ(a))||Ω|(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)×(|A|+m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a))α+δrρα−δrΓ(α+δr+1))≤[1ραΓ(α+1)(|(ψ(τ2)−ψ(a))α−(ψ(τ1)−ψ(a))α|+2(ψ(τ2)−ψ(τ1))α)+1|Ω|(|A|+m∑i=1|γi|Θ(ηi,α)+n∑j=1|κj|Θ(ξj,α−βj)+k∑r=1|σr|Θ(θr,α+δr))×|eρ−1ρ(ψ(τ2)−ψ(a))−eρ−1ρ(ψ(τ1)−ψ(a))|][2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0]. |
Clearly, which independent of u∈Br2 the above inequality, |(Ku)(τ2)−(Ku)(τ1)|→0 as τ2→τ1. Hence, by the Arzelá-Ascoli property, K:E→E is completely continuous.
Next, we will prove that there is B⊆E where B is an open set, u≠ϱK(u) for ϱ∈(0,1) and u∈∂B. Assume that u∈E is a solution of u=ϱKu, ϱ∈(0,1). Hence, it follows that
|u(t)|=|ϱ(Ku)(t)|≤|A||Ω|+(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)×[Θ(T,α)+1|Ω|(m∑i=1|γi|Θ(ηi,α)+n∑j=1|κj|Θ(ξj,α−βj)+k∑r=1|σr|Θ(θr,α+δr))]=|A||Ω|+(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)Λ, |
which yields
‖u‖≤|A||Ω|+(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)Λ. |
Consequently,
‖u‖|A||Ω|+(2p0Ψ(‖u‖)+f0Θ(T,ω)‖u‖1−q0)Λ≤1. |
By (H3), there is N so that ‖u‖≠N. Define
B={u∈E:‖u‖<N}andQ=B∩Br2. |
Note that K:¯Q→E is continuous and completely continuous. By the option of Q, there is no u∈∂Q so that u=ϱKu, ∃ϱ∈(0,1). Thus, (by Lemma 3.3), we conclude that K has fixed point u∈¯Q which verifies that (1.11) has at least one solution.
By applying Krasnoselskii's FPT, the existence property will be achieved.
Lemma 3.5. (Krasnoselskii's fixed point theorem [60]) Let M be a closed, bounded, convex and nonempty subset of a Banach space. Let K1, K2 be the operators such that (i) K1x+K2y∈M whenever x,y∈M; (ii) K1 is compact and continuous; (iii) K2 is contraction mapping. Then there exists z∈M such that z=K1z+K2z.
Theorem 3.6. Suppose that (H1) holds and f∈C(J×R4,R) so that:
(H4) ∃g∈C(J,R+) so that
f(t,u,v,w,z)|≤g(t),∀(t,u,v,w,z)∈J×R4. |
If
(2L1+L2Θ(T,ω)1−L3)(Λ−Θ(T,α))<1, | (3.10) |
then the Caputo-PFIDE with MNCs (1.11) has at least one solution.
Proof. Define supt∈J|g(t)|=‖g‖ and picking
r3≥|A||Ω|+‖g‖Λ, | (3.11) |
we consider Br3={u∈E:‖u‖≤r3}. Define K1 and K2 on Br3 as (3.2) and (3.3).
For any u,v∈Br3, we obtain
|(K1u)(t)+(K2v)(t)|≤supt∈J{ρIα,ψa+|Fu(t)|+eρ−1ρ(ψ(t)−ψ(a))|Ω|(|A|+m∑i=1|γi|ρIα,ψa+|Fv(ηi)|+n∑j=1|κj|ρIα−βj,ψa+|Fv(ξj)|+k∑r=1|σr|ρIα+δr,ψa+|Fv(θr)|)}≤|A||Ω|+‖g‖{(ψ(T)−ψ(a))αραΓ(α+1)+1|Ω|(m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a))α+δrρα+δrΓ(α+δr+1))}=|A||Ω|+‖g‖Λ≤r3. |
This implies that K1u+K2v∈Br3, which verifies Lemma 3.5 (i).
Next, we are going to show that Lemma 3.5 (ii) is verified.
Assume that un is a sequence so that un→u∈E as n→∞. Hence, we get
|(K1un)(t)−(K1u)(t)|≤ρIα,ψa+|Fun−Fu|(T)≤Θ(T,α)‖Fun−Fu‖. |
Since f is continuous, verifies that Fu is also continuous. By the Lebesgue dominated convergent theorem, we have
|(K1un)(t)−(K1u)(t)|→0asn→∞. |
Therefore,
‖K1un−K1u‖→0asn→∞. |
Thus, implies that K1u is continuous. Also, the set K1Br3 is uniformly bounded as
‖K1u‖≤Θ(T,α)‖g‖. |
Next step, we will show the compactness of K1.
Define sup{|f(t,u,v,w,z)|;(t,u,v,w,z)∈J×R4}=f∗<∞, thus, for each τ1,τ2∈J with τ1≤τ2, it follows that
|(K1u)(τ2)−(K1u)(τ1)|=|ρIα,ψa+[Fu(τ2)]−ρIα,ψa+[Fu(τ1)]|≤1ραΓ(α+1)(|(ψ(τ2)−ψ(a))α−(ψ(τ1)−ψ(a))α|+2(ψ(τ2)−ψ(τ1))α)f∗. |
Clearly, the right-hand side of the above inequality is independent of u and |(K1u)(τ2)−(K1u)(τ1)|→0, as τ2→τ1. Hence, the set K1Br3 is equicontinuous, also K1 maps bounded subsets into relatively compact subsets, which implies that K1Br3 is relatively compact. By the Arzelá-Ascoli theorem, then K1 is compact on Br3.
Finally, we are going to show that K2 is contraction.
For each u, v∈Br3 and t∈J, we get
|(K2u)(t)−(K2v)(t)|≤1|Ω|(m∑i=1|γi|ρIα,ψa+|Fu−Fv|(ηi)+n∑j=1|κj|ρIα−βj,ψa+|Fu−Fv|(ξj)+k∑r=1|σr|ρIα+δr,ψa+|Fu−Fv|(θr))≤1|Ω|(m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a))α+δrρα+δrΓ(α+δr+1))×(2L1+L2Θ(T,ω)1−L3)‖u−v‖=(2L1+L2Θ(T,ω)1−L3)(Λ−Θ(T,α))‖u−v‖. |
Since (3.10) holds, implies that K2 is contraction and also Lemma 3.5 (iii) verifies.
Therefore, the assumptions of Lemma 3.5 are verified. Then, (by Lemma 3.5) which verifies that (1.11) has at least one solution.
This part is proving different kinds of US like HU stable, GHU stable, HUR stable and GHUR stable of the Caputo-PFIDE with MNCs (1.11).
Definition 4.1. The Caputo-PFIDE with MNCs (1.11) is called HU stable if there is a constant Δf>0 so that for every ϵ>0 and the solution z∈E of
|CρDα,ψa+[z(t)]−f(t,z(t),z(λt),ρIω,ψa+[z(λt)],CρDα,ψa+[z(λt)])|≤ϵ, | (4.1) |
there exists the solution u∈E of (1.11) so that
|z(t)−u(t)|≤Δfϵ,t∈J. | (4.2) |
Definition 4.2. The Caputo-PFIDE with MNCs (1.11) is called GHU stable if there is a function Φ∈C(R+,R+) via Φ(0)=0 so that, for every solution z∈E of
|CρDα,ψa+[z(t)]−f(t,z(t),z(λt),ρIω,ψa+[z(λt)],CρDα,ψa+[z(λt)])|≤ϵΦ(t), | (4.3) |
there is the solution u∈E of (1.11) so that
|z(t)−u(t)|≤Φ(ϵ),t∈J. | (4.4) |
Definition 4.3. The Caputo-PFIDE with MNCs (1.11) is called HUR stable with respect to Φ∈C(J,R+) if there is a constant Δf,Φ>0 such that for every ϵ>0 and for any the solution z∈E of (4.3) there is the solution u∈E of (1.11) so that
|z(t)−u(t)|≤Δf,ΦϵΦ(t),t∈J. | (4.5) |
Definition 4.4. The Caputo-PFIDE with MNCs (1.11) is called GHUR stable with respect to Φ∈C(J,R+) if there is a constant Δf,Φ>0 so that for any the solution z∈E of
|CρDα,ψa+[z(t)]−f(t,z(t),z(λt),ρIω,ψa+[z(λt)],CρDα,ψa+[z(λt)])|≤Φ(t), | (4.6) |
there is the solution u∈E of (1.11) so that
|z(t)−u(t)|≤Δf,ΦΦ(t),t∈J. | (4.7) |
Remark 4.5. Cleary, (i) Definition 4.1 ⇒ Definition 4.2; (ii) Definition 4.3 ⇒ Definition 4.4; (iii) Definition 4.3 for Φ(t)=1 ⇒ Definition 4.1.
Remark 4.6. z∈E is the solution of (4.1) if and only if there is the function w∈E (which depends on z) so that: (i) |w(t)|≤ϵ, ∀t∈J; (ii) CρDα,ψa+[z(t)]=Fz(t)+w(t), t∈J.
Remark 4.7. z∈E is the solution of (4.3) if and only if there is the function v∈E (which depends on z) so that: (i) |v(t)|≤ϵΦ(t), ∀t∈J; (ii) CρDα,ψa+[z(t)]=Fz(t)+v(t), t∈J.
From Remark 4.6, the solution of
CρDα,ψa+[z(t)]=f(t,z(t),z(λt),ρIω,ψa+[z(λt)],CρDα,ψa+[z(λt)])+w(t),t∈J, |
can be rewritten as
z(t)=ρIα,ψa+[Fz(t)]+eρ−1ρ(ψ(t)−ψ(a))Ω(A−m∑i=1γiρIα,ψa+[Fz(ηi)]−n∑j=1κjρIα−βj,ψa+[Fz(ξj)]−k∑r=1σrρIα+δr,ψa+[Fz(θr)])+ρIα,ψa+[w(t)]−eρ−1ρ(ψ(t)−ψ(a))Ω(m∑i=1γiρIα,ψa+[w(ηi)]+n∑j=1κjρIα−βj,ψa+[w(ξj)]+k∑r=1σrρIα+δr,ψa+[w(θr)]). | (4.8) |
Firstly, the key lemma that will be applied in the presents of HU stable and GHU stable.
Lemma 4.8. Assume that 0<ϵ,ρ≤1. If z∈E verifies (4.1), hence z is the solution of
|z(t)−(Kz)(t)|≤Λϵ, | (4.9) |
where Λ is given as in (3.5).
Proof. By Remark 4.6 with (4.8), it follows that
|z(t)−(Kz)(t)|=|ρIα,ψa+[w(t)]−eρ−1ρ(ψ(t)−ψ(a))Ω(m∑i=1γiρIα,ψa+[w(ηi)]+n∑j=1κjρIα−βj,ψa+[w(ξj)]+k∑r=1σrρIα+δr,ψa+[w(θr)])|≤ρIα,ψa+|w(T)|+1|Ω|(m∑i=1|γi|ρIα,ψa+|w(ηi)|+n∑j=1|κj|ρIα−βj,ψa+|w(ξj)|+k∑r=1|σr|ρIα+δr,ψa+|w(θr)|)≤[(ψ(T)−ψ(a))αραΓ(α+1)+1|Ω|(m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a))α+δrρα+δrΓ(α+δr+1))]ϵ=Λϵ, |
where Λ is given by (3.5), from which (4.9) is achieved.
Next, we will show the HU and GHU stability results.
Theorem 4.9. Suppose that f∈C(J×R4,R). If (H1) is verified with (3.6) trues. Hence the Caputo-PFIDE with MNCs (1.11) is HU stable as well as GHU stable on J.
Proof. Assume that z∈E is the solution of (4.1) and assume that u is the unique solution of
{CρDα,ψa+[u(t)]=f(t,u(t),u(λt),ρIω,ψa+[u(λt)],CρDα,ψa+[u(λt)]),t∈(a,T),λ∈(0,1),m∑i=1γiu(ηi)+n∑j=1κjCρDβj,ψa+[u(ξj)]+k∑r=1σrρIδr,ψa+[u(θr)]=A. |
By using |x−y|≤|x|+|y| with Lemma 4.8, one has
|z(t)−u(t)|=|z(t)−ρIα,ψa+[Fu(t)]−eρ−1ρ(ψ(t)−ψ(a))Ω(A−m∑i=1γiρIα,ψa+[Fu(ηi)]−n∑j=1κjρIα−βj,ψa+[Fu(ξj)]−k∑r=1σrρIα+δr,ψa+[Fu(θr)])|=|z(t)−(Kz)(t)+(Kz)(t)−(Ku)(t)|≤|z(t)−(Kz)(t)|+|(Kz)(t)−(Ku)(t)|≤Λϵ+(2L1+L2Θ(T,ω)1−L3)Λ|z(t)−u(t)|, |
where Λ is given as in (3.5). This offers |z(t)−u(t)|≤Δfϵ, where
Δf=Λ1−(2L1+L2Θ(T,ω)1−L3)Λ. | (4.10) |
Then, the Caputo-PFIDE with MNCs (1.11) is HU stable. In addition, if we input Φ(ϵ)=Δfϵ via Φ(0)=0, hence (1.11) is GHU stable.
Thanks of Remark 4.7, the solution
CρDα,ψa+[z(t)]=f(t,z(t),z(λt),ρIω,ψa+[z(λt)],CρDα,ψa+[z(λt)])+v(t),t∈(a,T], |
can be rewritten as
z(t)=ρIα,ψa+[Fz(t)]+eρ−1ρ(ψ(t)−ψ(a))Ω(A−m∑i=1γiρIα,ψa+[Fz(ηi)]−n∑j=1κjρIα−βj,ψa+[Fz(ξj)]−k∑r=1σrρIα+δr,ψa+[Fz(θr)])+ρIα,ψa+[v(t)]−eρ−1ρ(ψ(t)−ψ(a))Ω(m∑i=1γiρIα,ψa+[v(ηi)]+n∑j=1κjρIα−βj,ψa+[v(ξj)]+k∑r=1σrρIα+δr,ψa+[v(θr)]). | (4.11) |
For the next proving, we state the following assumption:
(H5) there is an increasing function Φ∈C(J,R+) and there is a constant nΦ>0, so that, for each t∈J,
ρIα,ψa+[Φ(t)]≤nΦΦ(t). | (4.12) |
Lemma 4.10. Assume that z∈E is the solution of (4.3). Hence, z verifies
|z(t)−(Kz)(t)|≤ΛϵnΦΦ(t),0<ϵ≤1. | (4.13) |
where Λ is given as in (3.5).
Proof. From (4.11), we have
|z(t)−(Kz)(t)|=|ρIα,ψa+v(t)−eρ−1ρ(ψ(t)−ψ(a))Ω(m∑i=1γiρIα,ψa+[v(ηi)]+n∑j=1κjρIα−βj,ψa+[v(ξj)]+k∑r=1σrρIα+δr,ψa+[v(θr)])|≤[ρIα,ψa+[Φ(T)]+1|Ω|(m∑i=1|γi|ρIα,ψa+[Φ(ηi)]+n∑j=1|κj|ρIα−βj,ψa+[Φ(ξj)]+k∑r=1|σr|ρIα+δr,ψa+[Φ(θr)])]ϵ≤[(ψ(T)−ψ(a))αραΓ(α+1)+1|Ω|(m∑i=1|γi|(ψ(ηi)−ψ(a))αραΓ(α+1)+n∑j=1|κj|(ψ(ξj)−ψ(a))α−βjρα−βjΓ(α−βj+1)+k∑r=1|σr|(ψ(θr)−ψ(a)big)α+δrρα+δrΓ(α+δr+1))]ϵnΦΦ(t)=ΛϵnΦΦ(t), |
where Λ is given by (3.5), which leads to (4.13).
Finally, we are going to show HUR and GHUR stability results.
Theorem 4.11. Suppose f∈C(J×R4,R). If (H1) is satisfied with (3.6) trues. Hence, the Caputo-PFIDE with MNCs (1.11) is HUR stable as well as GHUR stable on J.
Proof. Assume that ϵ>0. Suppose that z∈E is the solution of (4.6) and u is the unique solution of (1.11). By using the triangle inequality, Lemma 4.8 and (4.11), we estamate that
|z(t)−u(t)|=|z(t)−ρIα,ψa+[Fu(t)]−eρ−1ρ(ψ(t)−ψ(a))Ω(A−m∑i=1γiρIα,ψa+[Fu(ηi)]−n∑j=1κjρIα−βj,ψa+[Fu(ξj)]−k∑r=1σrρIα+δr,ψa+[Fu(θr)])|=|z(t)−(Kz)(t)+(Kz)(t)−(Ku)(t)|≤|z(t)−(Kz)(t)|+|(Kz)(t)−(Kx)(t)|≤ΛϵnΦΦ(t)+(2L1+L2Θ(T,ω)1−L3)Λ|z(t)−u(t)|, |
where Λ is given as in (3.5), verifies that |z(t)−u(t)|≤Δf,ΦϵΦ(t), where
Δf,Φ:=ΛnΦ1−(2L1+L2Θ(T,ω)1−L3)Λ. |
Then, the Caputo-PFIDE with MNCs (1.11) is HUR stable. In addition, if we input Φ(t)=ϵΦ(t) with Φ(0)=0, then (1.11) is GHUR stable.
This part shows numerical instances that demonstrate the exactness and applicability of our main results.
Example 5.1. Discussion the following nonlinear Caputo-PFIDE with MNCs of the form:
{C23D12,√t0+[u(t)]=f(t,u(t),u(t√3),23I34,√t0+[u(t√3)],C23D12,√t[u(t√3)]0+),t∈(0,1),2∑i=1(i+12)u(2i+15)+3∑j=1(2j−15)C23D2j+120,√t0+[u(j4)]+2∑r=1(r3)23Irr+1,√t0+[u(r+14)]=1. | (5.1) |
Here, α=1/2, ρ=2/3, ψ(t)=√t, λ=1/√3, ω=3/4, a=0, T=1, m=2, n=3, k=2, γi=(i+1)/2, ηi=(2i+1)/5, i=1,2, κj=(2j−1)/5, βj=(2j+1)/20, ξj=j/4, j=1,2,3, σr=r/3, δr=r/(r+1), θr=(r+1)/4, r=1,2. By using Python, we obtain that Ω≈2.4309≠0 and Λ≈4.042711.
(I) If we set the nonlinear function
f(t,u,v,w)=13t+3(2+cos2t)(|u|1+|u|+|v|1+|v|+|w|1+|w|+|z|1+|z|). |
For any ui, vi, wi, zi∈R, i=1,2 and t∈[0,1], one has
|f(t,u1,v1,w1,z1)−f(t,u2,v2,w2,z2)|≤13t+3(|u1−u2|+|v1−v2|+|w1−w2|+|z1−z2|). |
The assumption (H1) is satisfied with L1=L2=L3=127. Hence
(2L1+L2Θ(T,ω)1−L3)Λ≈0.540287<1. |
All conditions of Theorem 3.2 are verified. Hence, the nonlinear Caputo-PFIDE with MNCs (5.1) has a unique solution on [0,1]. Moreover, we obtain
Δf=Λ1−(2L1+L2Θ(T,ω)1−L3)Λ≈8.793988>0. |
Hence, from Theorem 4.9, the nonlinear Caputo-PFIDE with MNCs (5.1) is HU stable and also GHU stable on [0,1]. In addition, by taking Φ(t)=eρ−1ρψ(t)(ψ(t)−ψ(0)), we have
23I12,ψ0+[Φ(t)]=2√2√3πe−0.5ψ(t)(ψ(t)−ψ(0))32≤2√2√3π(ψ(t)−ψ(0))12Φ(t). |
Thus, (4.12) is satisfied with nΦ=2√2√3π>0. Then, we have
Δf,Φ:=ΛnΦ1−(2L1+L2Θ(T,ω)1−L3)Λ≈8.102058>0. |
Hence, from Theorem 4.11, the nonlinear Caputo-PFIDE with MNCs (5.1) is HUR stable and also GHUR stable.
(II) If we take the nonlinear function
f(t,u,v,w)=14t+2(|u|+|v|1+|u|+|v|+12)+12t+3(|w|+|z|1+|w|+|z|+12), |
we have
|f(t,u,v,w,z)|≤14t+2(|u|+|v|+12)+12t+3(|w|+|z|+12). |
From the above inequality with (H2)–(H3), we get that p(t)=1/4t+2, Ψ(|u|+|v|)=|u|+|v|+1/2 and h(t)=q(t)=1/2t+3. So, we have p0=1/16 and h0=q0=1/8. From all the datas, we can compute that the constant N>0.432489. All assumptions of Theorem 3.4 are verified. Hence, the nonlinear Caputo-PFIDE with MNCs (5.1) has at least one solution on [0,1]. Moreover,
Δf:=Λ1−(2L1+L2Θ(T,ω)1−L3)Λ≈63.662781>0, |
Hence, from Theorem 4.9, the nonlinear Caputo-PFIDE with MNCs 5.1 is HU stable and also GHU stable on [0,1]. In addition, by taking Φ(t)=eρ−1ρψ(t)(ψ(t)−ψ(0))12, we have
23I12,ψ0+[Φ(t)]=√3π2√2e−0.5ψ(t)(ψ(t)−ψ(0))≤√3π2√2(ψ(t)−ψ(0))12Φ(t). |
Thus, (4.12) is satisfied with nΦ=√3π2√2>0. Then, we have
Δf,Φ:=ΛnΦ1−(2L1+L2Θ(T,ω)1−L3)Λ≈69.0997>0, |
Hence, from Theorem 4.11, the nonlinear Caputo-PFIDE with MNCs 5.1 is HUR stable and also GHUR stable on [0,1].
(III) If we set the nonlinear function
f(t,u,v,w)=14t+2(|u|+|v|1+|u|+|v|)+12t+3(|w|+|z|1+|w|+|z|). |
For ui, vi, wi, zi∈R, i=1,2 and t∈[0,1], we have
|f(t,u1,v1,w1,z1)−f(t,u2,v2,w2,z2)|≤14t+2(|u1−u2|+|v1−v2|)+12t+3(|w1−w2|+|z1−z2|). |
The assumption (H4) is satisfied with L1=L2=116, L3=18 and
|f(t,u,v,w,z)|≤14t+2+12t+3, |
which yields that
g(t)=14t+2+12t+3. |
Then
(2L1+L2Θ(T,ω)1−L3)(Λ−Θ(T,α))≈0.660387<1. |
All assumptions of Theorem 3.6 are verified. Hence the nonlinear Caputo-PFIDE with MNCs (5.1) has at least one solution on [0,1].
Furthermore, we get
Δf=Λ1−(2L1+L2Θ(T,ω)1−L3)Λ≈43.1392148>0. |
Hence, from Theorem 4.9, the nonlinear Caputo-PFIDE with MNCs (5.1) is HU stable and also GHU stable on [0,1]. In addition, by taking Φ(t)=eρ−1ρψ(t)(ψ(t)−ψ(0))2, we have
23I12,ψ0+[Φ(t)]=8√615√πe−0.5ψ(t)(ψ(t)−ψ(0))52≤8√615√π(ψ(t)−ψ(0))12Φ(t). |
Thus, (4.12) is satisfied with nΦ=8√615√π>0. Then, we have
Δf,Φ:=ΛnΦ1−(2L1+L2Θ(T,ω)1−L3)Λ≈31.79594>0. |
Hence, from Theorem 4.11, the nonlinear Caputo-PFIDE with MNCs (5.1) is HUR stable and also GHUR stable on [0,1].
Example 5.2. Discussion the following linear Caputo-PFIDE with MNCs of the form:
{C23Dα,ψ(t)0+[u(t)]=e−12ψ(t)(ψ(t)−ψ(0))12,t∈(0,1),2∑i=1(i+12)u(2i+15)+3∑j=1(2j−15)C23D2j+120,√t0+[u(j4)]+2∑r=1(r3)23Irr+1,√t0+[u(r+14)]=1. | (5.2) |
By Lemma 2.1, the implicit solution of the problem (5.2)
u(t)=Γ(32)(23)αΓ(32+α)e−12ψ(t)(ψ(t)−ψ(0))12+α+e−12(ψ(t)−ψ(0))Ω(1−2∑i=1(i+12)e−12ψ(2i+15)(ψ(2i+15)−ψ(0))12−3∑j=1(2j−15)Γ(32)(23)α−2j+120Γ(32+α−2j+120)e−12ψ(j4)(ψ(j4)−ψ(0))12+α−2j+120−2∑r=1(r3)Γ(32)(23)α+rr+1Γ(32+α+rr+1)e−12ψ(r+14)(ψ(r+14)−ψ(0))12+α+rr+1), |
where
Ω=2∑i=1(i+12)e−12(ψ(t)−ψ(0))+2∑r=1(r3)(ψ(r+14)−ψ(0))rr+1e−12(ψ(r+14)−ψ(0))(23)rr+1Γ(1+rr+1). |
We consider several cases of the following function ψ(t):
(I) If ψ(t)=tα then the solution of linear Caputo-PFIDE with MNCs (5.2) is given as in
u(t)=Γ(32)(23)αΓ(32+α)e−tα2(tα)1/2+α+e−tα2Ω(1−2∑i=1(i+12)e−12(2i+15)α(2i+15)α2−3∑j=1(2j−15)Γ(32)(23)α−2j+120Γ(32+α−2j+120)e−12(j4)α(j4)α(12+α−2j+120)−2∑r=1(r3)Γ(32)(23)α+rr+1Γ(32+α+rr+1)e−12(r+14)α(r+14)α(12+α+rr+1)), |
where
Ω=2∑i=1(i+12)e−tα2+2∑r=1(r3)(r+14)αrr+1e−12(r+14)α(23)rr+1Γ(1+rr+1). |
(II) If ψ(t)=sintα then the solution of linear Caputo-PFIDE with MNCs (5.2) is given as in
u(t)=Γ(32)(23)αΓ(32+α)e−sint2α(sintα)12+α+e−sint2αΩ(1−2∑i=1(i+12)e−sin(2i+15)2α(sin(2i+15)α)12−3∑j=1(2j−15)Γ(32)(23)α−2j+120Γ(32+α−2j+120)e−sin(j4)2α(sin(j4)α)12+α−2j+120−2∑r=1(r3)Γ(32)(23)α+rr+1Γ(32+α+rr+1)e−sin(r+14)2α(sin(r+14)α)12+α+rr+1), |
where
Ω=2∑i=1(i+12)e−sint2α+2∑r=1(r3)(sin(r+14)α)rr+1e−sin(r+14)2α(23)rr+1Γ(1+rr+1). |
(III) If ψ(t)=eαt then the solution of linear Caputo-PFIDE with MNCs (5.2) is given as in
u(t)=Γ(32)(23)αΓ(32+α)e−eαt2(eαt−1)12+α+e−eαt−12Ω(1−2∑i=1(i+12)e−eα(2i+15)2(eα(2i+15)−1)12−3∑j=1(2j−15)Γ(32)(23)α−2j+120Γ(32+α−2j+120)e−eαj42(eαj4−1)12+α−2j+120−2∑r=1(r3)Γ(32)(23)α+rr+1Γ(32+α+rr+1)e−eα(r+14)2(eα(r+14)−1)12+α+rr+1), |
where
Ω=2∑i=1(i+12)e−12(eαt−1)+2∑r=1(r3)(eα(r+14)−1)rr+1e−12(eα(r+14)−1)(23)rr+1Γ(1+rr+1). |
(IV) If ψ(t)=ln(1+t)α then the solution of linear Caputo-PFIDE with MNCs (5.2) is given as in
u(t)=Γ(32)(23)αΓ(32+α)e−12αln(1+t)(ln(1+t)α)1/2+α+e−12ln(1+t)Ω(1−2∑i=1(i+12α)e−12αln(1+2i+15)(1αln(1+2i+15)12−3∑j=1(2j−15)Γ(32)(23)α−2j+120Γ(32+α−2j+120)e−12αln(1+j4)(1αln(1+j4)12+α−2j+120−2∑r=1(r3)Γ(32)(23)α+rr+1Γ(32+α+rr+1)e−12αln(1+r+14)(1αln(1+r+14))12+α+rr+1), |
where
Ω=2∑i=1(i+12)e−12αln(1+t)+2∑r=1(r3)(1αln(1+r+14))rr+1e−12αln(1+r+14)(23)rr+1Γ(1+rr+1). |
Graph representing the solution of the problem (5.2) with various values α via many the functions ψ(t)=tα, ψ(t)=sintα, ψ(t)=eαt and ψ(t)=ln(1+t)α is shown as in Figures 1–4 by using Python.
The qualitative analysis is accomplished in this work. The authors proved the existence, uniqueness and stability of solutions for Caputo-PFIDE with MNCs which consist of multi-point and fractional multi-order boundary conditions. Some famous theorems are employed to obtain the main results such as the Banach's FPT is the important theorem to prove the uniqueness of the solution, while Leray-Schauder's nonlinear alternative and Krasnoselskii's FPT are used to investigate the existence results. Furthermore, we established the various kinds of Ulam's stability like HU, GHU, HUR and GHUR stables. Finally, by using Python, numerical instances allowed to guarantee the accuracy of the theoretical results.
This research would be a great work to enrich the qualitative theory literature on the problem of nonlinear fractional mixed nonlocal conditions involving a particular function. For the future works, we shall focus on studying the different types of existence results and stability analysis for impulsive fractional boundary value problems.
B. Khaminsou was supported by the International Science Programme PhD. Research Scholarship from National University of Laos (NUOL). W. Sudsutad was partially supported by Ramkhamhaeng University. C. Thaiprayoon and J. Kongson would like to thank for funding this work through the Center of Excellence in Mathematics (CEM), CHE, Sri Ayutthaya Road, Bangkok, 10400, Thailand and Burapha University.
On behalf of all authors, the corresponding author states that there is no conflict of interest.
[1] |
Wang G, Zhao G, Chao X, et al. (2020) The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. Int J Environ Res Public Health 17: 6278. https://doi.org/10.3390/ijerph17176278 ![]() |
[2] |
Martin RM, Bachman MA (2018) Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol 8. https://doi.org/10.3389/fcimb.2018.00004 ![]() |
[3] |
Remya PA, Shanthi M, Sekar U (2019) Characterisation of virulence genes associated with pathogenicity in Klebsiella pneumoniae. Indian J Med Microbiol 37: 210-218. https://doi.org/10.4103/ijmm.IJMM_19_157 ![]() |
[4] |
Russo TA, Olson R, Fang CT, et al. (2018) Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol 56. https://doi.org/10.1128/JCM.00776-18 ![]() |
[5] |
Maurya N, Jangra M, Tambat R, et al. (2019) Alliance of efflux pumps with beta-Lactamases in multidrug-resistant Klebsiella pneumoniae isolates. Microb Drug Resist 25: 1155-1163. https://doi.org/10.1089/mdr.2018.0414 ![]() |
[6] |
Pitout JD, Nordmann P, Poirel L (2015) Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59: 5873-5884. https://doi.org/10.1128/AAC.01019-15 ![]() |
[7] |
Iyer R, Moussa SH, Tommasi R, et al. (2019) Role of the Klebsiella pneumoniae TolC porin in antibiotic efflux. Res Microbiol 170: 112-116. https://doi.org/10.1016/j.resmic.2018.11.003 ![]() |
[8] |
Logan LK, Weinstein RA (2017) The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 215: S28-S36. https://doi.org/10.1093/infdis/jiw282 ![]() |
[9] |
Kumar S, Chaudhary M, Yadav M, et al. (2020) Global surveillance programs on antimicrobial resistance. Sustainable Agr Rev 46: 33-58. https://doi.org/10.1007/978-3-030-53024-2_2 ![]() |
[10] | Genovese C, La Fauci V, D'Amato S, et al. (2020) Molecular epidemiology of antimicrobial resistant microorganisms in the 21th century: a review of the literature. Acta Biomed 91: 256-273. https://doi.org/10.23750/abm.v91i2.9176 |
[11] |
Diancourt L, Passet V, Verhoef J, et al. (2005) Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43: 4178-82. https://doi.org/10.1128/JCM.43.8.4178-4182.2005 ![]() |
[12] |
Gaibani P, Ambretti S, Tamburini MV, et al. (2018) Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates. J Glob Antimicrob Resist 12: 169-170. https://doi.org/10.1016/j.jgar.2018.01.016 ![]() |
[13] |
Wang Q, Li B, Tsang AK, et al. (2013) Genotypic analysis of Klebsiella pneumoniae isolates in a Beijing hospital reveals high genetic diversity and clonal population structure of drug-resistant isolates. PLoS One 8: e57091. https://doi.org/10.1371/journal.pone.0057091 ![]() |
[14] |
Boom R, Sol CJ, Salimans MM, et al. (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495-503. https://doi.org/10.1128/jcm.28.3.495-503.1990 ![]() |
[15] |
Liu Y, Liu C, Zheng W, et al. (2008) PCR detection of Klebsiella pneumoniae in infant formula based on 16S-23S internal transcribed spacer. Int J Food Microbiol 125: 230-235. https://doi.org/10.1016/j.ijfoodmicro.2008.03.005 ![]() |
[16] |
Singh G, Biswal M, Hallur V, et al. (2015) Utility of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for the rapid detection of nosocomial outbreaks of multidrug resistant organisms: experience at a tertiary care center in North India. Indian J Med Microbiol 33: 221-224. https://doi.org/10.4103/0255-0857.154857 ![]() |
[17] |
Ghalavand Z, Heidary Rouchi A, Bahraminasab H, et al. (2018) Molecular testing of Klebsiella pneumoniae contaminating tissue allografts recovered from deceased donors. Cell Tissue Bank 19: 391-398. https://doi.org/10.1007/s10561-018-9684-3 ![]() |
[18] |
Hou XH, Song XY, Ma XB, et al. (2015) Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates. Braz J Microbiol 46: 759-768. https://doi.org/10.1590/S1517-838246320140138 ![]() |
[19] | Gao Y, Zhang L, Li MC, et al. (2010) Molecular typing of Klebsiella pneumonia by pulse-field gel electrophoresis in combination with multilocus sequence typing. Zhonghua Liu Xing Bing Xue Za Zhi 31: 786-790. |
[20] |
Han H, Zhou H, Li H, et al. (2013) Optimization of pulse-field gel electrophoresis for subtyping of Klebsiella pneumoniae. Int J Environ Res Public Health 10: 2720-2731. https://doi.org/10.3390/ijerph10072720 ![]() |
[21] |
Zakaria AM, Hassuna NA (2019) Modified PFGE protocol for improving typeability of DNA degradation susceptible nosocomial Klebsiella pneumoniae. J Med Microbiol 68: 1787-1792. https://doi.org/10.1099/jmm.0.001093 ![]() |
[22] |
Cheng F, Li Z, Lan S, et al. (2018) Characterization of Klebsiella pneumoniae associated with cattle infections in southwest China using multi-locus sequence typing (MLST), antibiotic resistance and virulence-associated gene profile analysis. Braz J Microbiol 49: 93-100. https://doi.org/10.1016/j.bjm.2018.06.004 ![]() |
[23] | Liu S, Wang X, Ge J, et al. (2021) Analysis of carbapenemase-resistant genotypes of highly virulent Klebsiella pneumoniae and clinical infection characteristics of different MLST types. Evid Based Complement Alternat Med 2021: 3455121. https://doi.org/10.1155/2021/3455121 |
[24] | Gona F, Comandatore F, Battaglia S, et al. (2020) Comparison of core-genome MLST, coreSNP and PFGE methods for Klebsiella pneumoniae cluster analysis. Microb Genom 6. https://doi.org/10.1099/mgen.0.000347 |
[25] |
Snitkin ES, Zelazny AM, Thomas PJ, et al. (2012) Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4: 148ra116. https://doi.org/10.1126/scitranslmed.3004129 ![]() |
[26] |
Founou RC, Founou LL, Allam M, et al. (2019) Whole genome sequencing of extended spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae isolated from hospitalized patients in KwaZulu-Natal, South Africa. Sci Rep 9: 6266. https://doi.org/10.1038/s41598-019-42672-2 ![]() |
[27] |
Nutman A, Marchaim D (2019) How to: molecular investigation of a hospital outbreak. Clin Microbiol Infect 25: 688-695. https://doi.org/10.1016/j.cmi.2018.09.017 ![]() |
[28] |
Ahmad S, Abulhamd A (2015) Phenotypic and molecular characterization of nosocomial K. pneumoniae isolates by ribotyping. Adv Med Sci 60: 69-75. https://doi.org/10.1016/j.advms.2014.10.003 ![]() |
[29] |
Schumann P, Pukall R (2013) The discriminatory power of ribotyping as automatable technique for differentiation of bacteria. Syst Appl Microbiol 36: 369-375. https://doi.org/10.1016/j.syapm.2013.05.003 ![]() |
[30] |
Manchanda V, Singh NP, Shamweel A, et al. (2006) Molecular epidemiology of clinical isolates of ampc producing Klebsiella pneumoniae. Indian J Med Microbiol 24: 177-181. ![]() |
[31] |
Aboulela A, El-Sherbini E, Abu-Sheasha G, et al. (2020) Molecular strain typing of multidrug-resistant Klebsiella pneumoniae: capsular wzi gene sequencing versus multiple locus variable number tandem repeat analysis. Diagn Microbiol Infect Dis 98: 115139. https://doi.org/10.1016/j.diagmicrobio.2020.115139 ![]() |
[32] |
Carattoli A, Bertini A, Villa L, et al. (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63: 219-228. https://doi.org/10.1016/j.mimet.2005.03.018 ![]() |
[33] |
Shankar C, Muthuirulandi Sethuvel DP, Neeravi AR, et al. (2020) Identification of plasmids by PCR based replicon typing in bacteremic Klebsiella pneumoniae. Microb Pathog 148: 104429. https://doi.org/10.1016/j.micpath.2020.104429 ![]() |
[34] |
Johnson TJ, Nolan LK (2009) Plasmid replicon typing. Methods Mol Biol 551: 27-35. https://doi.org/10.1007/978-1-60327-999-4_3 ![]() |
[35] |
Nielsen JB, Skov MN, Jorgensen RL, et al. (2011) Identification of CTX-M15-, SHV-28-producing Klebsiella pneumoniae ST15 as an epidemic clone in the Copenhagen area using a semi-automated Rep-PCR typing assay. Eur J Clin Microbiol Infect Dis 30: 773-778. https://doi.org/10.1007/s10096-011-1153-x ![]() |
[36] |
Genc S, Kolayli F, Ozcelik EY (2021) Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: the first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey. J Infect Chemother 28: 192-198. https://doi.org/10.1016/j.jiac.2021.10.009 ![]() |
[37] | Wu B, Wang Y, Ling Z, et al. (2020) Heterogeneity and diversity of mcr-8 genetic context in chicken-associated Klebsiella pneumoniae. Antimicrob Agents Chemother 65. https://doi.org/10.1128/AAC.01872-20 |
[38] |
Indrajith S, Mukhopadhyay AK, Chowdhury G, et al. (2021) Molecular insights of carbapenem resistance Klebsiella pneumoniae isolates with focus on multidrug resistance from clinical samples. J Infect Public Health 14: 131-138. https://doi.org/10.1016/j.jiph.2020.09.018 ![]() |
[39] |
Lopes E, Saavedra MJ, Costa E, et al. (2020) Epidemiology of carbapenemase-producing Klebsiella pneumoniae in northern Portugal: Predominance of KPC-2 and OXA-48. J Glob Antimicrob Resist 22: 349-353. https://doi.org/10.1016/j.jgar.2020.04.007 ![]() |
[40] |
Szymankiewicz M, Nowikiewicz T, Stefaniuk E, et al. (2021) Characteristics of ESBL-producing enterobacterales colonizing the gastrointestinal tract in patients admitted to the oncological hospital. Curr Microbiol 78: 642-648. https://doi.org/10.1007/s00284-020-02334-3 ![]() |
[41] |
Tot T, Kibel S, Sardelic S, et al. (2021) Polyclonal spread of colistin resistant Klebsiella pneumoniae in Croatian hospitals and outpatient setting. Germs 11: 163-178. https://doi.org/10.18683/germs.2021.1254 ![]() |
[42] |
Kumar S, Patil PP, Singhal L, et al. (2019) Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates reveals the emergence of blaOXA-23 and blaNDM-1 encoding international clones in India. Infect Genet Evol 75: 103986. https://doi.org/10.1016/j.meegid.2019.103986 ![]() |
[43] |
Chen CM, Wang M, Li XP, et al. (2021) Homology analysis between clinically isolated extraintestinal and enteral Klebsiella pneumoniae among neonates. BMC Microbiol 21: 25. https://doi.org/10.1186/s12866-020-02073-2 ![]() |
[44] |
Shankar C, Jacob JJ, Sugumar SG, et al. (2021) Distinctive mobile genetic elements observed in the clonal expansion of carbapenem-resistant Klebsiella pneumoniae in India. Microb Drug Resist 27: 1096-1104. https://doi.org/10.1089/mdr.2020.0316 ![]() |
[45] |
Banerjee T, Wangkheimayum J, Sharma S, et al. (2021) Extensively drug-resistant hypervirulent Klebsiella pneumoniae from a series of neonatal sepsis in a tertiary care hospital, India. Front Med (Lausanne) 8: 645955. https://doi.org/10.3389/fmed.2021.645955 ![]() |
[46] |
Wang CH, Ma L, Huang LY, et al. (2021) Molecular epidemiology and resistance patterns of blaOXA-48 Klebsiella pneumoniae and Escherichia coli: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect 54: 665-672. https://doi.org/10.1016/j.jmii.2020.04.006 ![]() |
[47] |
Silva-Sanchez J, Barrios-Camacho H, Hernandez-Rodriguez E, et al. (2021) Molecular characterization of KPC-2-producing Klebsiella pneumoniae ST258 isolated from bovine mastitis. Braz J Microbiol 52: 1029-1036. https://doi.org/10.1007/s42770-021-00445-y ![]() |
[48] |
Zhao W, Li S, Schwarz S, et al. (2021) Detection of a NDM-5-producing Klebsiella pneumoniae sequence type 340 (CG258) high-risk clone in swine. Vet Microbiol 262: 109218. https://doi.org/10.1016/j.vetmic.2021.109218 ![]() |
[49] |
Brahmia S, Lalaoui R, Nedjai S, et al. (2021) First clinical cases of KPC-2-Producing Klebsiella pneumoniae ST258 in Algeria and outbreak of Klebsiella pneumoniae ST101 harboring blaOXA-48 gene in the urology department of Annaba Hospital. Microb Drug Resist 27: 652-659. https://doi.org/10.1089/mdr.2020.0080 ![]() |
[50] |
Kumar S, Anwer R, Yadav M, et al. (2021) Molecular typing and global epidemiology of Staphylococcus aureus. Curr Pharmacol Rep 7: 179-186. https://doi.org/10.1007/s40495-021-00264-7 ![]() |
[51] |
Kumar S, Saifi Z, Sharma A, et al. (2020) Rapid identification of clinical isolates of Klebsiella pneumoniae using MALDI-TOF MS from North India. Bull Pure Appl Sci (Zoology) 39: 194-199. https://doi.org/10.5958/2320-3188.2020.00022.4 ![]() |
[52] | Gautam V, Sharma M, Singhal L, et al. (2017) MALDI-TOF mass spectrometry: an emerging tool for unequivocal identification of non-fermenting Gram-negative bacilli. Indian J Med Res 145: 665-672. https://doi.org/10.4103/ijmr.IJMR_1105_15 |
[53] |
Kumar S, Anwer R, Sehrawat A, et al. (2021) Assessment of bacterial pathogens in drinking water: a serious safety concern. Curr Pharmacol Rep 7: 206-212. https://doi.org/10.1007/s40495-021-00263-8 ![]() |
[54] |
Kumar S, Anwer R, Yadav M, et al. (2021) MALDI-TOF MS and molecular methods for identifying multidrug resistant clinical isolates of Acinetobacter baumannii. Res J Biotechnol 16: 47-52. ![]() |
[55] |
Pena I, Pena-Vina E, Rodriguez-Avial I, et al. (2022) Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates. Enferm Infecc Microbiol Clin (Engl Ed) 40: 172-178. https://doi.org/10.1016/j.eimc.2020.10.018 ![]() |
[56] |
Asencio-Egea MA, Gaitan-Pitera J, Huertas-Vaquero M, et al. (2021) Interhospital dissemination of KPC-3 producing-Klebsiella pneumoniae ST512. Detection by MALDI-TOF. Enferm Infecc Microbiol Clin (Engl Ed) 39: 83-86. https://doi.org/10.1016/j.eimc.2019.12.014 ![]() |
[57] |
Huang Y, Li J, Wang Q, et al. (2021) Rapid detection of KPC-producing Klebsiella pneumoniae in China based on MALDI-TOF MS. J Microbiol Methods 192: 106385. https://doi.org/10.1016/j.mimet.2021.106385 ![]() |
[58] |
Bridel S, Watts SC, Judd LM, et al. (2021) Klebsiella MALDI TypeR: a web-based tool for Klebsiella identification based on MALDI-TOF mass spectrometry. Res Microbiol 172: 103835. https://doi.org/10.1016/j.resmic.2021.103835 ![]() |
[59] |
Meng X, Yang J, Duan J, et al. (2019) Assessing molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae (CR-KP) with MLST and MALDI-TOF in Central China. Sci Rep 9: 2271. https://doi.org/10.1038/s41598-018-38295-8 ![]() |
[60] |
Purighalla S, Esakimuthu S, Reddy M, et al. (2017) Discriminatory power of three typing techniques in determining relatedness of nosocomial Klebsiella pneumoniae isolates from a tertiary hospital in India. Indian J Med Microbiol 35: 361-368. https://doi.org/10.4103/ijmm.IJMM_16_308 ![]() |
[61] | Elbehiry A, Marzouk E, Hamada M, et al. (2017) Application of MALDI-TOF MS fingerprinting as a quick tool for identification and clustering of foodborne pathogens isolated from food products. New Microbiol 40: 269-278. |
[62] |
Anwer R, Darami H, Almarri FK, et al. (2022) MALDI-TOF MS for rapid analysis of bacterial pathogens causing urinary tract infections in the Riyadh region. Diseases 10: 78. https://doi.org/10.3390/diseases10040078 ![]() |
[63] | Kumar S, Patil PP, Midha S, et al. (2015) Genome sequence of Acinetobacter baumannii Strain 5021_13, isolated from cerebrospinal fluid. Genome Announc 3. https://doi.org/10.1128/genomeA.01213-15 |
[64] | Kumar S, Patil PP, Midha S, et al. (2015) Genome sequence of Acinetobacter baumannii Strain 10441_14 belonging to ST451, isolated from India. Genome Announc 3. https://doi.org/10.1128/genomeA.01322-15 |
[65] |
Ben-Chetrit E, Mc Gann P, Maybank R, et al. (2021) Colistin-resistant Klebsiella pneumoniae bloodstream infection: old drug, bad bug. Arch Microbiol 203: 2999-3006. https://doi.org/10.1007/s00203-021-02289-4 ![]() |
[66] |
Sherif M, Palmieri M, Mirande C, et al. (2021) Whole-genome sequencing of Egyptian multidrug-resistant Klebsiella pneumoniae isolates: a multi-center pilot study. Eur J Clin Microbiol Infect Dis 40: 1451-1460. https://doi.org/10.1007/s10096-021-04177-7 ![]() |
[67] |
Gentile B, Grottola A, Orlando G, et al. (2020) A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant Klebsiella Pneumoniae nosocomial strains isolated during an MDR surveillance program. Antibiotics (Basel) 9: 246. https://doi.org/10.3390/antibiotics9050246 ![]() |
[68] |
Saavedra SY, Bernal JF, Montilla-Escudero E, et al. (2021) Complexity of genomic epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates in Colombia urges the reinforcement of whole genome sequencing-based surveillance programs. Clin Infect Dis 73: S290-S299. https://doi.org/10.1093/cid/ciab777 ![]() |
[69] |
Fu P, Tang Y, Li G, et al. (2019) Pandemic spread of blaKPC-2 among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids. Int J Antimicrob Agents 54: 117-124. https://doi.org/10.1016/j.ijantimicag.2019.03.014 ![]() |
[70] |
Yan Z, Zhou Y, Du M, et al. (2019) Prospective investigation of carbapenem-resistant Klebsiella pneumonia transmission among the staff, environment and patients in five major intensive care units, Beijing. J Hosp Infect 101: 150-157. https://doi.org/10.1016/j.jhin.2018.11.019 ![]() |
[71] |
Hu Y, Zhou H, Lu J, et al. (2021) Evaluation of the IR Biotyper for Klebsiella pneumoniae typing and its potentials in hospital hygiene management. Microb Biotechnol 14: 1343-1352. https://doi.org/10.1111/1751-7915.13709 ![]() |
[72] |
Kumar S, Anwer R, Yadav M, et al. (2022) An update on advancements in treatment options for managing Klebsiella pneumoniae infections. Curr Pharmacol Rep 8: 439-449. https://doi.org/10.1007/s40495-022-00302-y ![]() |
[73] |
Bernardini A, Cuesta T, Tomas A, et al. (2019) The intrinsic resistome of Klebsiella pneumoniae. Int J Antimicrob Agents 53: 29-33. https://doi.org/10.1016/j.ijantimicag.2018.09.012 ![]() |
[74] | Wattal C, Goel N, Oberoi JK, et al. (2010) Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India 58: 32-36. |
[75] | Codjoe FS, Donkor ES (2017) Carbapenem resistance: a review. Med Sci (Basel) 6. https://doi.org/10.3390/medsci6010001 |
[76] | Kumar S, Anwer R, Azzi A (2021) Virulence potential and treatment options of multidrug-resistant (MDR) Acinetobacter baumannii. Microorganisms 9. https://doi.org/10.3390/microorganisms9102104 |
[77] | AlQumaizi KI, Kumar S, Anwer R, et al. (2022) Differential gene expression of efflux pumps and porins in clinical isolates of MDR Acinetobacter baumannii. Life (Basel) 12. https://doi.org/10.3390/life12030419 |
[78] |
Gautam V, Kumar S, Patil PP, et al. (2020) Exploring the interplay of resistance nodulation division efflux pumps, Ampc and Oprd in antimicrobial resistance of Burkholderia cepacia complex in clinical isolates. Microb Drug Resist 26: 1144-1152. https://doi.org/10.1089/mdr.2019.0102 ![]() |
[79] | Kumar S, Singhal L, Ray P, et al. (2020) Over-expression of RND and MATE efflux pumps contribute to decreased susceptibility in clinical isolates of carbapenem resistant Acinetobacter baumannii. Int J Pharm Res 12: 342-349. |
[80] |
Turkel I, Yildirim T, Yazgan B, et al. (2017) Relationship between antibiotic resistance, efflux pumps, and biofilm formation in extended-spectrum beta-lactamase producing Klebsiella pneumoniae. J Chemother 30: 354-363. https://doi.org/10.1080/1120009X.2018.1521773 ![]() |
[81] |
Schaenzer AJ, Wright GD (2020) Antibiotic resistance by enzymatic modification of antibiotic targets. Trends Mol Med 26: 768-782. https://doi.org/10.1016/j.molmed.2020.05.001 ![]() |
[82] |
McDanel J, Schweizer M, Crabb V, et al. (2017) Incidence of extended-spectrum beta-lactamase (ESBL)-Producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review. Infect Control Hosp Epidemiol 38: 1209-1215. https://doi.org/10.1017/ice.2017.156 ![]() |
[83] |
Pulzova L, Navratilova L, Comor L (2017) Alterations in outer membrane permeability favor drug-resistant phenotype of Klebsiella pneumoniae. Microb Drug Resist 23: 413-420. https://doi.org/10.1089/mdr.2016.0017 ![]() |
[84] |
Lv F, Cai J, He Q, et al. (2021) Overexpression of efflux pumps mediate pan resistance of Klebsiella pneumoniae Sequence Type 11. Microb Drug Resist 27: 1405-1411. https://doi.org/10.1089/mdr.2020.0395 ![]() |
[85] |
Gao H, Liu Y, Wang R, et al. (2020) The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings. EBioMedicine 51: 102599. https://doi.org/10.1016/j.ebiom.2019.102599 ![]() |
[86] |
Tsioutis C, Eichel VM, Mutters NT (2021) Transmission of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: the role of infection control. J Antimicrob Chemother 76: i4-i11. https://doi.org/10.1093/jac/dkaa492 ![]() |
[87] | Shields RK, Chen L, Cheng S, et al. (2017) Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother 61. https://doi.org/10.1128/AAC.02097-16 |
[88] |
Shankar C, Karunasree S, Manesh A, et al. (2019) First report of whole-genome sequence of colistin-resistant Klebsiella quasipneumoniae subsp. similipneumoniae Producing KPC-9 in India. Microb Drug Resist 25: 489-493. https://doi.org/10.1089/mdr.2018.0116 ![]() |
[89] |
Yang Y, Ahmed M, Qin M, et al. (2022) Carriage of distinct blaKPC-2 and blaOXA-48 plasmids in a single ST11 hypervirulent Klebsiella pneumoniae isolate in Egypt. BMC Genomics 23: 20. https://doi.org/10.1186/s12864-021-08214-9 ![]() |
[90] |
Paul M (2021) Management of KPC-producing Klebsiella pneumoniae in clinical practice: introduction. J Antimicrob Chemother 76: i2-i3. https://doi.org/10.1093/jac/dkaa491 ![]() |
[91] |
Cano A, Gutierrez-Gutierrez B, Machuca I, et al. (2018) Risks of infection and mortality among patients colonized with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: validation of scores and proposal for management. Clin Infect Dis 66: 1204-1210. https://doi.org/10.1093/cid/cix991 ![]() |
[92] |
Bedenic B, Sardelic S, Luxner J, et al. (2016) Molecular characterization of class b carbapenemases in advanced stage of dissemination and emergence of class d carbapenemases in Enterobacteriaceae from Croatia. Infect Genet Evol 43: 74-82. https://doi.org/10.1016/j.meegid.2016.05.011 ![]() |
[93] |
Al-Agamy MH, Aljallal A, Radwan HH, et al. (2018) Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals. J Infect Public Health 11: 64-68. https://doi.org/10.1016/j.jiph.2017.03.010 ![]() |
[94] |
Amarsy R, Jacquier H, Munier AL, et al. (2021) Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: another nightmare. Am J Infect Control 49: 1324-1326. https://doi.org/10.1016/j.ajic.2021.07.004 ![]() |
[95] | Han R, Shi Q, Wu S, et al. (2020) Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol 10. https://doi.org/10.3389/fcimb.2020.00314 |
[96] |
Bayoumi MA, Hamid OM (2022) The emergence of carbapenem resistant Enterobacteriaceae producing GIM-1 and SIM-1 clinical isolates in Khartoum-Sudan. Infect Drug Resist 15: 2679-2684. https://doi.org/10.2147/IDR.S365983 ![]() |
[97] |
Poirel L, Castanheira M, Carrer A, et al. (2011) OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55: 2546-2551. https://doi.org/10.1128/AAC.00022-11 ![]() |
[98] |
Ma L, Wang JT, Wu TL, et al. (2015) Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan. PLoS One 10: e0139152. https://doi.org/10.1371/journal.pone.0139152 ![]() |
[99] |
Ortiz-Padilla M, Portillo-Calderon I, de Gregorio-Iaria B, et al. (2021) Interplay among different fosfomycin resistance mechanisms in Klebsiella pneumoniae. Antimicrob Agents Chemother 65. https://doi.org/10.1128/AAC.01911-20 ![]() |
[100] | Ito R, Mustapha MM, Tomich AD, et al. (2017) Widespread fosfomycin resistance in Gram-negative bacteria attributable to the chromosomal fosA gene. mBio 8. https://doi.org/10.1128/mBio.00749-17 |
[101] |
Li Y, Zheng B, Zhu S, et al. (2015) Antimicrobial susceptibility and molecular mechanisms of fosfomycin resistance in clinical Escherichia coli isolates in Mainland China. PLoS One 10: e0135269. https://doi.org/10.1371/journal.pone.0135269 ![]() |
[102] |
Castaneda-Garcia A, Blazquez J, Rodriguez-Rojas A (2013) Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics (Basel) 2: 217-236. https://doi.org/10.3390/antibiotics2020217 ![]() |
[103] | Nigiz S, Hazirolan G, Koseoglu Eser O, et al. (2021) First detection of Klebsiella pneumoniae isolate co-harboring fosfomycin resistance gene fosA3 and blactx-m among Gram negative urine isolates in a Turkish hospital. Microb Drug Resist 28. https://doi.org/10.1089/mdr.2021.0114 |
[104] |
Kashefieh M, Hosainzadegan H, Baghbanijavid S, et al. (2021) The molecular epidemiology of resistance to antibiotics among Klebsiella pneumoniae isolates in Azerbaijan, Iran. J Trop Med 2021. https://doi.org/10.1155/2021/9195184 ![]() |
[105] |
Baghbanijavid S, Kafil HS, Farajniya S, et al. (2021) The association of the phylogenetic typing of the Klebsiella pneumoniae isolates with antibiotic resistance. Emerg Med Int 2021. https://doi.org/10.1155/2021/1316992 ![]() |
[106] |
Liu P, Chen S, Wu ZY, et al. (2020) Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist 22: 238-243. https://doi.org/10.1016/j.jgar.2019.12.019 ![]() |
[107] |
Farfour E, Degand N, Riverain E, et al. (2020) Fosfomycin, from susceptibility to resistance: impact of the new guidelines on breakpoints. Med Mal Infect 50: 611-616. https://doi.org/10.1016/j.medmal.2020.07.003 ![]() |
[108] |
Liu Y, Lin Y, Wang Z, et al. (2021) Molecular mechanisms of colistin resistance in Klebsiella pneumoniae in a tertiary care teaching hospital. Front Cell Infect Microbiol 11: 673503. https://doi.org/10.3389/fcimb.2021.673503 ![]() |
[109] |
Jaidane N, Bonnin RA, Mansour W, et al. (2018) Genomic insights into colistin-resistant Klebsiella pneumoniae from a Tunisian teaching hospital. Antimicrob Agents Chemother 62. https://doi.org/10.1128/AAC.01601-17 ![]() |
[110] |
Cannatelli A, Giani T, D'Andrea MM, et al. (2014) MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 58: 5696-5703. https://doi.org/10.1128/AAC.03110-14 ![]() |
[111] |
Mmatli M, Mbelle NM, Maningi NE, et al. (2020) Emerging transcriptional and genomic mechanisms mediating carbapenem and polymyxin resistance in Enterobacteriaceae: a systematic review of current reports. mSystems 5. https://doi.org/10.1128/mSystems.00783-20 ![]() |
[112] |
Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30: 557-596. https://doi.org/10.1128/CMR.00064-16 ![]() |
[113] |
Liu YY, Wang Y, Walsh TR, et al. (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16: 161-168. https://doi.org/10.1016/S1473-3099(15)00424-7 ![]() |
[114] |
Li B, Yin F, Zhao X, et al. (2019) Colistin resistance gene mcr-1 mediates cell permeability and resistance to hydrophobic antibiotics. Front Microbiol 10: 3015. https://doi.org/10.3389/fmicb.2019.03015 ![]() |
[115] |
Palucha A, Mikiewicz B, Hryniewicz W, et al. (1999) Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother 44: 489-499. ![]() |
[116] |
Paterson DL, Ko WC, Von Gottberg A, et al. (2001) Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39: 2206-2212. ![]() |
[117] |
Bauernfeind A, Chong Y, Schweighart S (1989) Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17: 316-321. ![]() |
[118] |
Tangden T, Cars O, Melhus A, et al. (2010) Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 54: 3564-3568. https://doi.org/10.1128/AAC.00220-10 ![]() |
[119] |
Ur Rahman S, Ali T, Ali I, et al. (2018) The growing genetic and functional diversity of extended Spectrum Beta-lactamases. Biomed Res Int 2018: 9519718. https://doi.org/10.1155/2018/9519718 ![]() |
[120] |
Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686. https://doi.org/10.1128/CMR.18.4.657-686.2005 ![]() |
1. | Osama Moaaz, Ahmed E. Abouelregal, Meshari Alesemi, Moore–Gibson–Thompson Photothermal Model with a Proportional Caputo Fractional Derivative for a Rotating Magneto-Thermoelastic Semiconducting Material, 2022, 10, 2227-7390, 3087, 10.3390/math10173087 | |
2. | Shayma Adil Murad, Reny George, Certain Analysis of Solution for the Nonlinear Two-Point Boundary Value Problem with Caputo Fractional Derivative, 2022, 2022, 2314-8888, 1, 10.1155/2022/1385355 |